Parvovirus B19 VLP VP2 Recombinant ( Parvovirus B19 VLP VP2 )

Data sheet

Formulation

Parvovirus B19 VLP VP2 protein solution is supplied in 16mM Sodium phosphate pH-7.4, 120mM NaCl and 20% glycerol.

Purity

Greater than 80.0% as determined by SDS-PAGE.

Applications

Western blot with anti-Parvovirus B19 positive sera.

Description

Recombinant Parvovirus B19 VLP VP2 produced in SF9 is a glycosylated, polypeptide chain having a calculated molecular mass of 60,839 Dalton. Parvovirus B19 VLP VP2 is purified by proprietary chromatographic techniques.

Protein Background

The B19 virus, usually referred to as parvovirus B19 or sometimes as erythrovirus B19, belongs to the family of parvoviruses, genus erythrovirus. B19 virus causes a childhood rash named fifth disease or erythema infectiosum which is ordinarily known as sl

Expression host

Sf9 insect cells.

Reagent Appearance

Sterile Filtered clear solution.

Stability

Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. Avoid multiple freeze-thaw cycles.

Immunological functions

1. Binds IgG-type human antibodies.2. Immunodot test with positive/negative sera.